Fidelity Investments’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
2015
Q1
$541M Buy
2014
Q4
$425M Buy
2014
Q3
$267M Buy
2014
Q2
$378M Buy
2014
Q1
$223M Sell
2013
Q4
$197M Sell
2013
Q3
$202M Buy
2013
Q2
$118M Buy